EICHORCondition: Insomnia Disorder · Sponsor: Vanda Pharmaceuticals
Sponsor, CRO or site team? See where this study is running → — listed sites, countries and recruiting context. Everything below is written for patients and caregivers.
This is a multicenter, double-blind, randomized study to evaluate the efficacy and safety of a daily single oral dose of tasimelteon and matching placebo in male and female pediatric participants with insomnia disorder.
This description comes directly from the study's public registry record.
Vanda Pharmaceuticals, Inc. · 202-734-3400 · VEC162@vandapharma.com
Always discuss trial participation with your own doctor first.
| Vanda Investigational Site | Dothan, Alabama, United States | Recruiting |
| Vanda Investigational Site | Phoenix, Arizona, United States | Recruiting |
| Vanda Investigational Site | Irvine, California, United States | Recruiting |
| Vanda Investigational Site | Miami, Florida, United States | Recruiting |
| Vanda Investigational Site | Miami Lakes, Florida, United States | Recruiting |
| Vanda Investigational Site | Winter Park, Florida, United States | Recruiting |
| Vanda Investigational Site | Snellville, Georgia, United States | Recruiting |
| Vanda Investigational Site | Stockbridge, Georgia, United States | Recruiting |
| Vanda Investigational Site | Naperville, Illinois, United States | Recruiting |
| Vanda Investigational Site | Worcester, Massachusetts, United States | Recruiting |
| Vanda Investigational Site | Great Falls, Montana, United States | Recruiting |
| Vanda Investigational Site | Lincoln, Nebraska, United States | Active Not Recruiting |
+ 23 more locations — full list on the registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice. By subscribing you agree to our Terms of Use and Privacy Policy.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06953869